Literature DB >> 10048736

Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study.

M Rasmussen1, O Kronborg, C Fenger, O D Jørgensen.   

Abstract

BACKGROUND: Flexible sigmoidoscopy (FS) has been recommended as a screening method to reduce mortality from colorectal cancer (CRC). The present study evaluates the effect of adding FS to the fecal occult blood test Hemoccult-II (H-II) on diagnostic yield of colorectal neoplasia.
METHODS: A total of 10,978 normal persons aged 50-75 years were invited to participate, 5495 persons being allocated at random to H-II and FS and 5483 to H-II alone.
RESULTS: In spite of a lower compliance (40% versus 56%) for the combined procedure, the diagnostic yield of colorectal neoplasia was higher than for H-II alone (12 CRC versus 4 CRC, and 72 large adenomas versus 14). Within 24-62 months after screening there were fewer CRCs detected after H-II + FS than after H-II alone. The stage distribution was less favorable than in screen-detected cases.
CONCLUSION: One FS may not be an optimal way of screening, but FS deserves to be evaluated in randomized population studies including repeated H-II tests in the control arm.

Entities:  

Mesh:

Year:  1999        PMID: 10048736     DOI: 10.1080/00365529950172862

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  17 in total

1.  Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

2.  [Staging of colorectal cancer. Official recommendations of the Canadian Study Group on Preventive Medicine].

Authors: 
Journal:  Can Fam Physician       Date:  2001-09       Impact factor: 3.275

3.  Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care.

Authors: 
Journal:  Can Fam Physician       Date:  2001-09       Impact factor: 3.275

4.  [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].

Authors:  A Eickhoff; C Maar; B Birkner; J F Riemann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

5.  Screening for colon cancer.

Authors:  J P Heiken
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

6.  Canadian guidelines for colorectal cancer screening.

Authors:  Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2011-09       Impact factor: 3.522

Review 7.  [Early diagnosis of colorectal tumors].

Authors:  C Lamberti; T Sauerbruch
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

8.  Is There a Place for Screening Flexible Sigmoidoscopy?

Authors:  Doron Boltin; Yaron Niv
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03

9.  Cancer screening trials: nuts and bolts.

Authors:  Philip C Prorok; Pamela M Marcus
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

10.  Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.

Authors:  Geir Hoff; Tom Grotmol; Eva Skovlund; Michael Bretthauer
Journal:  BMJ       Date:  2009-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.